Transcutaneous Spinal Cord Stimulation for Motor Recovery After Spinal Cord Injury
Restoring Upper and Lower Extremity Functions in Persons With Spinal Cord Injury by Transcutaneous Spinal Cord Stimulation
This study will examine the safety, feasibility, and potential benefits of transcutaneous spinal cord stimulation (scTS) combined with activity-based training in people with spinal cord injury.
The study will include 10 adults with chronic, incomplete spinal cord injury. Electrical stimulation will be delivered through electrodes placed on the skin over different regions of the spinal cord, while participants perform exercises involving the arms, hands, trunk, and legs.
Participants will undergo initial assessments, individualized stimulation mapping, and 80 training sessions, followed by final assessments. Researchers will evaluate changes in motor function, muscle activity, psychological well-being, autonomic function, and quality of life. Safety and tolerability will also be monitored throughout the study.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
This prospective, single-arm, within-subject exploratory study will enroll 10 adults aged 18-65 years with chronic incomplete cervical or thoracic spinal cord injury.
The study includes four phases: (1) baseline assessments over approximately two months; (2) stimulation mapping and optimization over approximately 0.5-1 month to identify individualized stimulation parameters; (3) 80 sessions of multisegment transcutaneous spinal cord stimulation combined with activity-based training, delivered 3-5 days per week over approximately 4-7 months; and (4) follow-up assessments.
The intervention targets upper and lower extremity function, trunk control, standing, and stepping. Motor performance will be assessed primarily using the Neuromuscular Recovery Scale (NRS). Additional assessments will examine muscle activation using electromyography (EMG), psychological symptoms, autonomic function, neurological status, spasticity, functional independence, and quality of life.
Intermediate assessments will be conducted during the intervention, including after 40 training sessions. Safety, adverse events, and feasibility will be evaluated throughout the study.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Amihai Gottlieb, Ph.D
- Telefonnummer: +972543323180
- E-mail: amihai.gottlieb@gmail.com
Studiesteder
-
-
-
Ramat Gan, Israel
- Sheba Medical Center
-
Kontakt:
- Amihai Gottlieb
- Telefonnummer: +972543323180
- E-mail: amihai.gottlieb@gmail.com
-
Underforsker:
- Einat Haber, M.D.
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- At least 18 years of age.
- Non-progressive cervical or thoracic (>T10) spinal cord injury (SCI), with the ability to voluntarily move at least three joints below the injury level.
- At least 6 months post spinal cord injury.
- Stable medical condition.
- Neuromuscular Recovery Scale (NRS) score <4C on any upper extremity, trunk, or standing/stepping item.
Exclusion Criteria:
- Ventilator dependence.
- Untreated or unstable fracture or pressure ulcer.
- Untreated psychiatric disorder or ongoing drug abuse.
- Cardiac, respiratory, bladder, renal, or other medical disorder that may interfere with the study.
- Skeletal muscle Botox injections within the previous 6 months.
- Previous nerve or tendon transfer of the arms or legs.
- Any implanted pump (e.g., baclofen pump or pain pump).
- Unable or unwilling to discontinue anti-spasticity medications.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Multisegment scTS + Activity-Based Training
Participants will receive individualized multisegment transcutaneous spinal cord stimulation (scTS) combined with activity-based training targeting upper and lower extremity function, trunk control, standing, and stepping. The intervention will consist of 80 training sessions, delivered 3-5 days per week over approximately 4-7 months, with sessions lasting up to 2 hours. |
Non-invasive electrical stimulation delivered through surface electrodes placed over multiple spinal levels using the NeoStim-5 system. Stimulation sites and parameters will be individually optimized to facilitate motor activation of the upper extremities, trunk, and lower extremities during activity-based training. Individualized, task-specific rehabilitation training targeting voluntary control of the hands, arms, trunk, and legs, including seated activities, standing, and stepping. Training will be provided by rehabilitation staff and combined with transcutaneous spinal cord stimulation. |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Motor Function (NRS)
Tidsramme: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
Changes in motor performance assessed using the Neuromuscular Recovery Scale (NRS), which evaluates movement quality and the level of assistance required during upper extremity, trunk, standing, and stepping tasks. Changes in individual task ratings will be assessed across study time points. |
Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
|
Safety
Tidsramme: From enrollment through the final study assessment (approximately 7-10 months per participant).
|
Incidence of adverse events and equipment-related complications during the study. Adverse events will be categorized by severity, relatedness to study procedures, and expectedness. |
From enrollment through the final study assessment (approximately 7-10 months per participant).
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Surface EMG Amplitude During Functional Motor Tasks
Tidsramme: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
Changes in surface electromyography (EMG) signal amplitude during functional motor tasks involving upper extremity, trunk, and lower extremity muscles. |
Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
|
Depression (PHQ-9)
Tidsramme: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
Changes in depressive symptoms measured using the 9-item Patient Health Questionnaire (PHQ-9). Total scores range from 0 to 27, with higher scores indicating greater depressive symptom severity. |
Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
|
Anxiety (GAD-7)
Tidsramme: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
Changes in anxiety symptoms measured using the 7-item Generalized Anxiety Disorder scale (GAD-7). Total scores range from 0 to 21, with higher scores indicating greater anxiety symptom severity. |
Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
|
PTSD (PCL-5)
Tidsramme: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training)
|
Changes in self-reported post-traumatic stress symptoms measured using the PTSD Checklist for DSM-5 (PCL-5). Total scores range from 0 to 80, with higher scores indicating greater symptom severity. |
Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training)
|
|
PTSD (CAPS-5)
Tidsramme: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
Changes in clinician-rated post-traumatic stress symptom severity measured using the CAPS-5. The total severity score ranges from 0 to 80, with higher scores indicating greater symptom severity. |
Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
|
Change in ISNCSCI Total Motor Score
Tidsramme: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
Change in motor function assessed using the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI). The total motor score ranges from 0 to 100, with higher scores indicating better motor function. |
Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
|
Change in Modified Ashworth Scale (MAS) Score
Tidsramme: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
Change in muscle spasticity assessed by a clinician using the Modified Ashworth Scale, which grades resistance to passive movement. |
Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
|
Change in Spinal Cord Injury Spasticity Evaluation Tool (SCI-SET) Score
Tidsramme: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
Change in the self-reported impact of spasticity on daily activities, assessed using the SCI-SET questionnaire covering the preceding seven days. |
Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
|
Change in Autonomic Dysfunction Following Spinal Cord Injury (ADFSCI) Questionnaire Score
Tidsramme: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
Change in frequency and severity of symptoms associated with blood pressure instability, assessed using the 24-item ADFSCI questionnaire. |
Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
|
Change in Modified Functional Reach Test Distance
Tidsramme: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
Change in maximum forward reaching distance while seated, measured using the Modified Functional Reach Test |
Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
|
Change in Activity-Based Balance Level (ABLE) Sitting Subscale Score
Tidsramme: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
Change in sitting balance assessed using the seven items of the ABLE sitting subscale, with a maximum score of 32. |
Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- SHEBA-26-3283-GZ-CTIL
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .